Last reviewed · How we verify

NCT05451693

Outreach-ER: A Dementia Care Intervention Program

Terminated Results posted Last updated 5 February 2025
What this trial tests

trial testing Outreach-ER in Dementia in 8 participants. Terminated before completion.

Timeline
8 September 2022
Primary endpoint
27 January 2023
30 March 2023

Quick facts

Lead sponsorHealthPartners Institute
StatusTerminated
Study typeOBSERVATIONAL
Enrollment8
Start date8 September 2022
Primary completion27 January 2023
Estimated completion30 March 2023
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

HealthPartners Institute

Who can join

18 and older, any sex, with Dementia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Attempted Recruits for Feasibility and Acceptability of Outreach-ER Primary · 4 months

Number of potential participant/care partner dyads contacted. Higher number indicates higher number of attempts as recruitment.

GroupValue95% CI
Outreach-ER32
Recruitment Rate for Feasibility and Acceptability of Outreach-ER Primary · 4 months

Percentage of participant/care partner dyads who enroll and consent \[range: 0-100%\]. Higher number indicates more feasibility.

GroupValue95% CI
Outreach-ER13
Participant Rate for Feasibility and Acceptability of Outreach-ER Primary · First day of intervention

Percentage of participant/care partner dyads who start Outreach-ER program \[range: 0-100%\]. Higher number indicates more feasibility.

GroupValue95% CI
Outreach-ER13
Completion Rate for Feasibility and Acceptability of Outreach-ER Primary · about 4 months

Percentage of participant/care partner dyads who complete intervention (7 or more visits) \[range: 0-100%\]. Higher number indicates more feasibility.

GroupValue95% CI
Outreach-ER75
Session Specific Completion Rate for Feasibility and Acceptability of Outreach-ER Primary · about 4 months

Percentage of participant/care partner dyads who complete each intervention visit \[range: 0-100%\]. Number of total intervention visits completed = total completed visits for the 4 dyads. Number of total intervention visits available = 6 visits x 4 dyads = 24 visits. Number of total intervention visits completed/24 total intervention visits x 100 = percentage. Higher number indicates more feasibility.

GroupValue95% CI
Outreach-ER86
Questionnaire Specific Response Rate for Feasibility and Acceptability of Outreach-ER Primary · about 4 months

Percentage of participant/care partner dyads who complete each questionnaire \[range: 0-100%\]. Number of total questionnaires completed = total completed questionnaires for the 4 dyads. Number of total questionnaires available = 3 questionnaires x 4 dyads x 2 visit time points = 24 available questionnaires. Number of total questionnaires completed/24 total questionnaires available x 100 = percentage. Higher number indicates more feasibility.

GroupValue95% CI
Outreach-ER67
Completeness of Specific Measures for Feasibility and Acceptability of Outreach-ER Secondary · about 4 months

Percentage of care partners that respond to all of the items on each scale \[range: 0-100%\]. Higher number indicates more feasibility.

GroupValue95% CI
Outreach-ER75

Sponsor's own description

This is a feasibility/pilot, prospective cohort study to determine how to implement and refine Outreach-ER intervention for a larger clinical study. A key feature of Outreach-ER is to reach out to people living with dementia (PLWD) and their families following an emergency room visit or hospitalization. The outcome of this study will help in the overall goal of studying the impact of Outreach-ER in a larger clinical study and focus on outcomes relevant to PLWD and their care partners.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dementia

Currently open trials in the same condition.

Other HealthPartners Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05451693.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing